Ginglival Health Among Smokers Visiting Dental Hospital
Launched by PAKISTAN INSTITUTE OF MEDICAL SCIENCES · May 16, 2024
Trial Information
Current as of February 12, 2025
Completed
Keywords
ClinConnect Summary
A total of 300 dental patients who visited the School of Dentistry, Islamabad, participated voluntarily in this study. The nicotine-consuming participants involved in this study were Smoke-Form users (S-form), Electronic cigarette-form users (E-form), and Dual-Form users (D-form) whose Gingival Index (G-I) was inspected to demonstrate an association between their smoking type and duration of developing severe gingivitis. The G-I ranging between 0.5 - 2.00 was used to calculate the occurrence of severe gingival issues in participants with smoking habits where G-I between 0.50 1.00 displayed ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Smokers with good general health status visiting dental hospital
- Exclusion Criteria:
- • Non-smoker dental patients
Trial Officials
Afsheen Mansoor
Principal Investigator
Pakistan Institute of Medical Sciences
About Pakistan Institute Of Medical Sciences
The Pakistan Institute of Medical Sciences (PIMS) is a premier healthcare institution dedicated to advancing medical research and clinical excellence in Pakistan. With a focus on innovative therapies and patient-centered care, PIMS plays a pivotal role in conducting clinical trials that contribute to the development of new treatments and improve health outcomes. The institute is equipped with state-of-the-art facilities and a multidisciplinary team of healthcare professionals, ensuring rigorous adherence to ethical standards and regulatory requirements in all research activities. Through collaboration with national and international partners, PIMS aims to enhance medical knowledge and promote evidence-based practices in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Islamabad, , Pakistan
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0